Print

Purpose

This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Confirmed positive test result for SARS-CoV-2 - Mechanically ventilated - Endotracheal tube inner diameter of at least 7.5 mm

Exclusion Criteria

  • Unable to provide informed consent (or surrogate) - Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials - Pregnant women

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
Intubated patients with confirmed SARS-CoV-2 will receive UV light treatment to potentially reduce bacterial and viral burden.
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Endotracheal UV Light 		Mechanically ventilated patients who will receive UV Light therapy
  • Device: UV Light Treatment
    UV light therapy administered while patient is mechanically ventilated

Recruiting Locations

More Details

NCT ID
NCT04572399
Status
Completed
Sponsor
Cedars-Sinai Medical Center

Detailed Description

This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.